Are you at risk for colorectal cancer? Answer these 13 questions in less than 1 minute to find out.
Our Clinical Trial Finder is a one-stop place to find and learn more about high-impact research studies for patients with advanced CRC. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status.
The Colorectal Cancer Care Initiative (CRCCI), led by Fight Colorectal Cancer, is a coalition of survivors, healthcare professionals and industry innovators uniting to transform colorectal cancer care.
Shop our online store to raise awareness everywhere you go! From t-shirts and fanny packs to patient education resources, we have a little bit of everything.
Raise Awareness. Be an Advocate. Host an Event.
Program Status Clinical trial’s patient recruitment status
Phase Phase of the clinical trial that is recruiting (I, II, or III)
Prior Immunotherapy Allowed Whether the clinical trial is open to patients who have received prior immunotherapy
CRC-directed Trial A flag to indicate whether the trial is specifically targeting colon cancer, rectal cancer, or colorectal cancer patients
Drugs Therapeutics used in the clinical trial
Tags
Comments
Phase III BREAKWATER trial. Only for patients with BRAF V600E–mutated, stage IV (metastatic) CRC, who are about to the receive their FIRST LINE of treatment, in the metastatic setting. Trial compares: 1. encorafenib (Braftovi) plus cetuximab (Erbitux) vs. 2. encorafenib (Braftovi) plus cetuximab (Erbitux) plus standard-of-care (SOC) chemotherapy vs. 3. chemotherapy alone